Pfizer Inc. and BioNTech SE’s COVID-19 vaccine gained a largely positive recommendation for use in children age 5 to 11 despite many unanswered questions on potentially influential topics.
Pfizer AdComm Asks Many Questions About COVID Vaccine For Ages 5-11, But Gets Few Answers
Often data was not available from FDA, CDC or the sponsor to answer subgroup, safety and other questions that could have influenced the outcome of the advisory committee meeting.
